Tag Archives: COVID-19

“Moderna” revealed that it is working on a third experimental dose of the Coronavirus vaccine, targeting a new mutated strain of the virus. The company indicated that it shipped doses of the new vaccine to the National Institutes of Health for clinical trials, explaining that “Moderna is committed to making …

Pfizer announced on Thursday that they haven’t seen any evidence that circulating variants of the coronavirus result in a loss of the protection provided by the vaccine they developed with BioNTech, as reported by Reuters. “We haven’t observed changes to neutralizing antibody levels that would predict a significant reduction in protection …

On Tuesday, February 9th, Britian recorded another decrease in the daily number of new cases of COVID-19, despite an increase in the number of deaths. Tests confirmed that 12,364 people were infected with the virus, in the latest daily toll, down from 14,104 cases yesterday, Monday. The number of new …

Pfizer expects to generate about $ 15 billion in sales this year from the COVID-19 vaccine it developed with its German partner BioNTech. The company achieved sales of the vaccine valued at $ 154 million in the fourth quarter, and the company expects adjusted full-year earnings of $ 3.10 per …

The International Monetary Fund (IMF) is now more optimistic about the recovery of the global economy, as shown by the latest World Economic Outlook released on Tuesday. The IMF sees the global economy growing by 5.5% in 2021, compared with its expectations in October of 5.2% growth. As for 2022, …

A British study conducted on health care workers found that those infected with Covid-19 were most likely to have immunity from the disease for at least five months, but there is evidence that those carrying antibodies may carry and spread the virus. And the preliminary results reached by scientists at …

The British health ministry announced on Friday that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved Moderna’s COVID-19 vaccine for use, as reported by Reuters. The health ministry further noted that they have ordered 10 million additional doses of Moderna’s vaccine to bring the total to 17 million …

The British government has recommended giving a second dose of the vaccine with a gap of 12 weeks instead of two weeks, in an effort to give more people a first dose and some initial protection against Covid-19. Accordingly, BioNTech and Pfizer responded to the decision, saying that there is …

According to the latest headlines floating on the wires, the UK confirmed that regulators have approved the use of the AstraZeneca/Oxford coronavirus vaccine. The UK health department announced that the government has accepted the recommendation by the MHRA to authorise the vaccine for use in the UK.

Pfizer and BioNTech announced on Wednesday that they will be supplying the US with 100 million additional doses of the COVID-19 vaccine, as reported by Reuters. All 200 million doses purchased by the US is expected to be delivered by July 31, 2021, the statement revealed.